Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals Ltd has announced the opening of its buyback offer in newspaper advertisements published on May 7, 2026. The company completed dispatch of the Letter of Offer dated May 6, 2026 to all eligible shareholders holding equity shares as on the Record Date (May 4, 2026). The buyback is scheduled to open on May 8, 2026 and close on May 14, 2026. Eligible shareholders are entitled to 47 equity shares for every 637 shares held, with separate entitlements for Small Shareholders (7.38%) and General Category shareholders (7.38%). The buyback is being conducted in compliance with SEBI Buy-Back of Securities Regulations, 2018.
Shareholders holding shares as of the Record Date can participate in the buyback by tendering their shares. The fixed window of May 8-14, 2026 provides a defined timeline for participation.